Gyrus Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Growth, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Austria, Netherlands, Hungary, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia, Romania
Industries Focus
- Healthcare
- Life Sciences
- Healthcare Services
- Diagnostics
- Biotech
- Sustainability
- Medtech
- Fashion
- Circular Economy
- Lifestyle
- Digital Transformation
- Automation
- Energy Transition
- Resource Efficiency
- Animal Health
Investment Size:
50,000,000 to 500,000,000 USD
Investor Details Founded: 2018
Gyrus Capital is a Geneva-based private equity firm specializing in transformational investments within the healthcare and sustainability sectors. Founded in 2018, the firm focuses on markets characterized by long-term growth, aiming to deliver efficiency through resilient business models. Gyrus Capital seeks to identify and invest in companies that address structural needs in society and the environment, positioning them for sustainable, long-term growth.
The firm's investment strategy emphasizes complex transactions, particularly corporate carve-outs and entrepreneur successions, targeting companies with enterprise values between €50 million and €500 million. Gyrus Capital's sector focus includes healthcare, encompassing pharmaceuticals, medical technology, life sciences, diagnostics, healthcare services, and animal health, as well as sustainability sectors such as digital transformation, automation, energy transition, resource efficiency, and the circular economy.
Gyrus Capital's approach is characterized by a partnership model that enables founders and managers to unlock transformational value. The firm has a track record of navigating complex deals, providing solutions to corporates in carve-outs and spin-offs, and actively engaging with management teams to drive change and value creation. Notable investments include the acquisition of a majority stake in ACBC, a leading sustainability service provider in the fashion industry, and the recapitalization of Essential Pharma, a global specialty pharmaceutical group.
Requirements
- Companies addressing structural needs in society and the environment
- Enterprise value between €50 million and €500 million
- Positioned for long-term, sustainable growth
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- ACBC
- Essential Pharma
- dss+
- Intellera Consulting
- Neo Medical
- ANYbotics
- Amazentis
- Neurosterix
Claim this Investor
Are you an official representative of Gyrus Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim